About
Liquid Biopsy
Areas of Focus
Categories
Diagnostics
Team (18)
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
4
As Collaborator
1
Total Enrollment
657
By Phase
PHASE2: 1PHASE3: 3
By Status
RECRUITING: 2COMPLETED: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06809803Collaborator
Extended-release Sodium Oxybate in Children
PHASE2Recruiting
36 participants
Started: Jul 31, 2025 · Completed: Jul 31, 2027
NCT06525077Lead Sponsor
Safety and Efficacy of FT218 in Idiopathic Hypersomnia (REVITALYZ)
PHASE3Recruiting
150 participants
Started: Aug 1, 2024 · Completed: Sep 30, 2026
NCT06792708Lead Sponsor
Observational Study of LUMRYZ in Narcolepsy
N/AActive, not recruiting
75 participants
Started: Jul 18, 2024 · Completed: Oct 31, 2025
NCT04451668Lead Sponsor
An Open Label Study of FT218 in Subjects With Narcolepsy
PHASE3Completed
184 participants
Started: Jun 12, 2020 · Completed: Nov 18, 2024
NCT02720744Lead Sponsor
Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy
PHASE3Completed
212 participants
Started: Nov 17, 2016 · Completed: Mar 25, 2020
Locations (1)
Headquarters
Toronto, ON, Canada
Map
Loading map...